High Yield vs. Policy Risk: What Buffett’s Latest Portfolio Moves Reveal

TradingKey - Warren Buffett’s Berkshire Hathaway has disclosed its latest portfolio adjustments, signaling a shift in asset allocation strategy amid growing macroeconomic uncertainty. The firm has significantly increased its stake in Sirius XM (SIRI.US) while continuing to trim its holdings in healthcare provider DaVita (DVA.US).

According to recent regulatory filings, between July 31 and August 4, Berkshire purchased over 5.03 million shares of Sirius XM, with a total value exceeding $106 million, bringing its total holdings to more than 124.8 million shares.

Sirius XM, a leading satellite radio company in North America, primarily serves automotive users with subscription-based content including music, talk shows, and sports. The company is known for its high user retention and stable earnings model. According to UBS, Sirius XM represents a core component of the emerging “in-car economy,” and Buffett’s increased exposure is viewed as a bet on the rise of smart vehicles and the associated growth in in-car content consumption.

At the same time, Berkshire sold approximately 1.63 million shares of DaVita, cashing out about $230 million. The move follows a previous reduction of 200,000 shares in May. While Berkshire remains one of DaVita’s largest shareholders, the continued selloff reflects growing caution over policy headwinds and Medicare-related reimbursement risk in the dialysis service sector.

Market analysts note that the portfolio adjustments point to a strategic shift away from healthcare assets vulnerable to regulatory intervention, and toward businesses with subscription-based models and strong, counter-cyclical cash flows. In the context of elevated interest rates and an uncertain economic outlook, Berkshire’s positioning highlights a preference for stable cash flow and long-term customer engagement.

Policy Risk Rising

Last week, former President Donald Trump sent letters to 17 global pharmaceutical giants, urging them to substantially lower drug prices in the U.S.. The move could further compress profit margins across the pharmaceutical sector and affect downstream healthcare providers such as DaVita.

Moreover, the proposed “American Beauty Act” aims to reduce Medicaid coverage, potentially disqualifying millions of low-income Americans from public health insurance. Analysts estimate that the policy may result in the loss of up to 500,000 healthcare-related jobs over the next decade and weaken demand for pharmaceuticals and medical supplies.

Institutional Commentary

Barron’s noted that this is Berkshire’s first purchase of Sirius XM since February, and suggested that the firm is likely attracted by the company’s resilient subscription revenue model and strong free cash flow, which tend to perform well in uncertain macro environments.

TipRanks pointed out that Sirius XM’s high dividend yield is a significant factor driving continued interest from Berkshire, aligning with its long-standing preference for stable income-generating assets.

You can also follow our star investors to keep up with Buffett's holdings.